Andreas Fibig: Thank you, Rich.As we look ahead, there are several potential near term catalysts that we believe will provide tailwinds. From a sales perspective, taste volumes are starting to rebound as Rich just mentioned, which we expect to increase mid-single digits in quarter four as destocking ends. In scent, we will capitalize on a 450 million incremental excess via additional three global coreless assuming we only achieve our fair share that can provide a couple of percentage points of growth over the next few years.And Frutarom we expect to see improving cleanse as Q3 was better than Q2 and Q4 was expected to be better than Q3. Then as we cycle transitory issues which highlighted [indiscernible] to our mid-single digit trend. To compliment this cross selling benefits are expected to trade approximately 100 million by the end of 2021.From a profitability perspective, we expect to benefit from acquisition related cost synergies. 2019 have already had great success achieving 50 million savings for the full year and expect the incremental benefits, we will be no less than an additional $50 million in 2020 as we are internally targeting more.At the core, we will also deliver on the 100 million productivity initiatives we outlined at our Investor Day. About one-third will be achieved in 2019, two-thirds coming in 2020 and 2021. And finally, we're starting to see signs of raw material deflation following a 20% increase we experienced over the past two years.Translating this into go forward financials, we continue to expect to deliver 5% to 7% currency neutral sales growth and a 10% plus in adjusted EPS excluding amortization, including both cross selling benefits and bolt-on acquisitions.In summary, the third quarter was a quarter of good progress, with positive momentum building. We delivered a sequential improvement in growth and achieved adjusted operating profit margin expansion excluding amortization via synergies, productivity and cost management.We are confident in our execution of our integration plan and in turn have to live at increased cost synergies in year one. We have started quarter four strong and given this trend, we are reconfirming our full year 2019 financial guidance.Looking beyond 2019, we have strong value creation opportunities via many near term catalysts. I'll pause forward is clear deliver strong value creation for all of our stakeholders, the growth acceleration, margin expansion and a successful integration.With that operator, we are now happy to take questions.
Andreas Fibig: Okay, Mark. Good morning, first of all. It's Andreas. Let me get started. So from the visit visibility point of view, we have already five weeks, which I think is good. We see what we have in the order book and we have in particular on the taste side, very, very strong win rates. So, these are the things which make us confident for the first quarter. And as you just mentioned, we have the 53rd week as well. So, all-in-all we see good development starting into the first quarter. And in particular we are happy about taste, that we had a couple of quarters which were not going so well. Certainly, again, a very, very strong comparison last year, but that's turning the corner quite rapidly and absolutely in the right direction, but Rich might add to that.
Andreas Fibig: Look, we Mark we have a lot of positives and I actually believe we will start in the next year was quite a bit of tail wind. Let me talk about it. The first one is, is certainly that we see that the tastes volumes are rebounding very, very strongly. So that's one which is really important because it has direct us down in 2019 then we have now these more core lists with our scent business which gives us access to 450 million in incremental sales potential. And we see that we have already won some businesses with these customers this year, which will then materialize next year. So, that's another an important move for more forward. We are lapping some of the Frutarom transitory challenges like citrus source for example.And then, the brush share case so that that's a good thing as well and thing which talked always to it that we can see a good mid single digit gross for the assets from mid, mid of next year. So that's good. And what we do makes me very optimistic is that we see the first nice cross-selling wins. We have this as an extra budget line in. We have a very, very strong pipeline of more than 800 projects already, which is really, really, really good. And on top of it, if you take a very close look to the cost synergies, we are very happy what the organization has delivered this year in particular on procurement savings because procurement is so important because it doesn't distract the organization from anything. And we're delivering all cost savings in general this year of 50 million, which is way above what we had expected and we call this at tailwind into 2020 as well.Then the usual core productivity programs which are running. And then, we see some tailwind on the [indiscernible] as well. So that's, I think these are a lot of very strong positive scoring are going forward. Certainly hedging in FX might be a bit of a headwind, but it all depends on the currencies develops, but Rich, you might comment on that.
Andreas Fibig: We have seen a couple of these segments within the legacy Frutarom business like inclusions where we have good double-digit growth and we believe that this will continue going forward.
Andreas Fibig: Yes. And what helps us as well as that Nicholas and his business unit have done a good job to keep let's say take some structural cost outs to be very competitive in this field and that's helping here as well.
Andreas Fibig: Yes, absolutely. And that's a very, very good point. We have seen it in that very quarter, but it's already rebounding strongly in the fourth quarter. I would say it's a transitory topic for the quarter driven by vanilla in a sense that some of the customers went from a natural vanilla to more the one and the synthetic solutions, which is good from a profitability point of view, but not so good from the sales point of point of view. And we see now a good start into the quarter. So I would not interpret too much into it. The concept stays and the concept survives. So, we are doing very well here..
Andreas Fibig: That's absolutely, look, listen, we will see the turnaround already in the fourth quarter. What we have seen in the first five weeks and what is in the order book looks, looks very, very strong and usually the business goes a little bit in [waves here] [ph] and we are not on the upswing right now. We see a good demand in many areas in particular in very innovative areas. We see it in, in the plant based proteins for example, which is becoming a really important driver of the business. We see that we have more of these solutions available. So the portfolio we inherited through Frutarom, which is helping as well. Some of it will be accounted in the cross selling and total solution space. So, we are actually very optimistic that this is going in the right direction and the team is thriving.And what I just said for taste point is actually important as well because certainly the last quarter was not great for taste point, but we are seeing a good rebounding on this one with many of our core call customers and we see in particular also a good winning on the beverage side, which is very helpful. So all in all, all the signs are very, very positive on that business. And I think that the team is fairly optimistic and motivated for the next couple of quarters.
Andreas Fibig: What is really exciting on this area as well as that the reason why we spent good amount of CapEx, this year is to modernize much of our manufacturing footprint where a lot of more OpEx and AI goes in, which will help us in the mid and long-term to a very competitive manufacturing costs in place. And that's helping as well. And that's what Rich said, because we have to finish up a couple of projects in Asia, which will have, we are just building the most modern and biggest flavors and fragrance manufacturing plant in India. We're doing something in China and in Indonesia. And also with the optimization of the footprint we bring in a lot of technology which will help us to come to a very, very competitive manufacturing costs.
Andreas Fibig: Yes. It's also cleaning up all of these documents we have screened. So, Deloitte and some of our legal partners here as well, I think in the first quarter we should be fine with that.
Andreas Fibig: Thank you very much for all the good questions and the attendance here. And we will follow-up with was one-on-one sessions with many of you. Thank you. Take care.
Richard O'Leary: Yes, Mark. I think you are right. If you recall, the comment I made was that as the trend continues through the end of the quarter, we're on target to exceed the mid-single-digit, which includes the 53rd week. So and doing that would enable us to get to the low-end of the guidance.
Richard O'Leary: Yes. Look, I think Mark, there are -- as you said, I think when you look at absolute year-over-year, there's going to be some headwinds from currency. We don't have the 53rd week. So that could be, 50, 60 basis point headwind year-over-year. We do get the benefits from cross-selling. I think the fundamentals are strong and I think that's what we feel good about. As I said and as Andreas mentioned, is how I said on the last call. I think it's going to be more towards the middle of next year when we lap some of these transitory issues. So I'm not ready to say we're going to get to the 60% next year because I think we have clearly some transitory issues we have to work through. But the foundation solid and I do think the long-term, our beliefs are that the long-term growth potential is there and that view hasn't changed.
Richard O'Leary: Yes, John. I think it's, look at, you look at the underlying mix of businesses and the categories. That's the right way to think about it that it's an above average grower. Once we cycle through that those transitory issues, some of which will continue into next year. But yes, that's, that's consistent with our view.
Richard O'Leary: Yes. From an overall profitability standpoint, if you include the synergies, it's not a hit, right? I mean from an exclusive of the borrowing cost and the cost of capital. But from a growth standpoint, we move forward some of these businesses that we're cycling through that we've talked about in the past, citrus source, the trade and marketing, some of the compliance related stuff, our lower margin is lower than average margin profiles compared to the overall Frutarom level. So, so as we've cycled that, there's a -- actually a favorable pickup going forward. So I think, overall, it's not that much of a drag in terms of from a P&L standpoint. Great. Thank you.
Richard O'Leary: I think for me, Lauren, we have to think about is that they're still at elevated levels. I mean, I think we're starting to see some signs of stabilization. As I look at sort of the net of input cost to raw material -- pricing of raw material costs, they were definitely a negative for the first half of the year. Q3 were basically breakeven and I expect it to be slightly favorable in Q4.
Richard O'Leary: Let me just make sure I get the three different items in the question, Gunther. So, first let me start with October. It is currency neutral organic growth, so it excludes the M&A and that's the results through the first five weeks of Q4. In terms of CapEx next year, I would expect this to be around 4.5% plus or minus, we're still working through that, but it's the peak year in terms of '19 to '20 as we've talked about. We're finishing up a couple of the key investments in Asia, India and Indonesia. We've got the probably the peak of the integration CapEx. And then, from there we all move down pretty quickly into 2021 going forward along the lines of the 3.5% that I've talked about previously.In terms of the synergy guidance, just keep in mind, where are we seeing the traction and where we've -- over-delivered in 2019 is really on the procurement side. I think we're very, very confident in our ability to deliver that. Obviously that, plateaus and I think we still have a lot of work to be done next year, particularly around the footprint and the site integration work. So it's a little bit early for me to raise the target from the 145, as I said in my comments, I think it puts us on a trajectory to do that, but I'm not ready to declare victory.
Richard O'Leary: No. I think from a big picture standpoint, we're on all the core list that we want to be on. And where it makes sense is to be on it beyond the coreless from an, from an economic standpoint. Certain of our customers are not performing as well. When you look at a two-year trend, for the first nine months of the year you adjust for the peer-based currency dynamic. We're very close to our largest competitor. So, I think we don't believe that we are fundamentally losing share and that we're performing well in the market and once we pass the transitory issue.So, I think we're the best thing we're doing and we're focused on, is actually carrying on our plan. Andreas has talked about the opportunity we have going forward on the scent side in terms of nearly $450 million in core lists access, as, we progressed on that that provides real upside to the scent business. I talked about some of the commentary around. On the legacy taste business about the order book and win rates being up significantly year-over-year, that bodes well for the future. So, I don't know if there's -- look, we have to execute and battle every day and we compete every day. And that's what we're focused on.
Richard O'Leary: Yes. So I mean, it's, I would say we're on track to deliver the a hundred million that we've talked about remember there's different components of it. A big part of it is in the scent business, on the cost transformation line -- that part of it is in the early stages now. What you're seeing some of the charges for relate to on the scent side, the overhead, the realignment of the business, finance transformation is some what we're going through now. I think we're going to basically deliver probably a little less than a third this year and then the remaining two-thirds equally over 2020 and 2021.
Richard O'Leary: Heidi, look as we go through the normal process at the end of the year, it's a required update in the disclosure. Look, at this point I consider it unlikely that we'll have impairment. And as I said earlier, we haven't changed our change, our view on the long-term impacts and potential of this business. So, I consider it unlikely.
Richard O'Leary: Yes. I think it's consistent with our plan. To me, I look at it as it helps us accelerate the de-leveraging plan the cost of capital to do the factoring on a short-term borrowing rates versus our long-term cost of capital rates. It's an attractive trade-off. And so, we're being opportunistic about that aspect.
Richard O'Leary: No, John, I mean, you know, I think there's a couple of different pieces there. I think when you ask where the growth rates were and Q3 being flat versus our expectations obviously is below where we wanted it to be and where we expected to be. It's driven by some of the transitory issues that I talked about previously in terms of colors issue and in [NPS] [ph], the trade and marketing the citrus source businesses.So, if I look at the core taste part of the business as you call on a Q2 call, we talked about a very challenging June in the taste business, particularly in Europe. Some of that continued into Q3, but again, we've seen a good start to Q4 and than certainly higher where we saw in Q3 all for four regions in the taste of Frutarom as well as for the savory business. And that's why I think ultimately, we have the confidence in the structural capability of that business.In terms of impacts related to integration, the reason why we're highlighting the procurement savings is that's really what's accelerating and what's changed. The biggest driver or difference in terms of our expected synergies -- that started the year at 30 to 35 and where we are now in 50. We're making -- we are on target and we are making good progress against the site rationalization you saw on -- I think it was Andreas' comments when we talked about the number of closes we've announced. So far and completed in the second half of this year. That will accelerate into 2020 and that's a big part of the driver of the increased synergies year-over-year between '19 and '20. I think from a, you get to the point about businesses that are -- on less attractive margin profile, profitability profile. I think that's more of a mix effect that we'll see going forward.
Richard O'Leary: Excuse me. For the first part on the working capital piece of it, it might have a small impact on what we typically did before, but it's not, it's not a huge program. I mean, I still expect to get the -- the improvement in Q4 that we typically see given the cyclicality and the way things operate in the fourth quarter. In terms of new capacity input costs, I think certainly the first thing is that we've seen, I'll say a stabilization of the supply chain. And that's the starting point. I mean if you think about what I talked about, Q2, Q1 was they were still a lot of volatility out there.Inventory levels remain high on the scent business for us and our competition, but we are seeing signs that as I said, that it starting to stabilize and I think the industry as a whole is starting to rebalance inventories and get away from safety stocks. The talk that we saw some improvement in Q3 in terms of inventory levels coming down. I expect that to continue in Q4. There's new capacity coming on from VASF in the fourth quarter. I think some of the capacity that was out of the market because of the fires is coming back on. And I think that helps provide a trajectory going forward for us to reduce inventory levels. And provide, as Andreas said, we're starting to see some signs that we may have some easing next year or going forward.
Richard O'Leary: Yes. I mean we're substantially complete in terms of doing the investigation as in anything like this, there's things that have to -- we have to finish putting, resolving issues whether it's people that are on garden leave that have to then go through. But it's the normal sort of follow up and clean up that that has as a result of something like that.
